PMGC HOLDINGS INC. Convertible Debt, Current
PMGC HOLDINGS INC. (ELAB) had Convertible Debt, Current of $9.08 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2026-08-14
- 2026-06-30: Convertible Debt, Current $9.08M.
- 2026-03-31: Convertible Debt, Current $5.24M.
- 2025-12-31: Convertible Debt, Current $1.25M.
- 2025-09-30: Convertible Debt, Current $3.19M.
| Period end | Convertible Debt, Current |
|---|---|
| 2026-06-30 | $9.08M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $5.24M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.25M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $3.19M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |